Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoyao Heji is a traditional Chinese medicine (TCM) compound oral liquid formulation. Its main ingredients include Bupleurum (柴胡), Angelica sinensis (当归), Paeonia lactiflora (白芍), Atractylodes macrocephala (白术), Poria cocos (茯苓), Glycyrrhiza uralensis processed with honey (炙甘草), Mentha haplocalyx (薄荷), and fresh ginger (生姜)[1][5]. The formula is designed to "soothe the liver, strengthen the spleen, nourish blood, and regulate menstruation." It is primarily indicated for symptoms associated with liver qi stagnation such as irregular menstruation, chest/flank distension or pain, dizziness, loss of appetite, and related gynecological or digestive complaints[5][8]. The mechanism of action is based on TCM theory rather than modern molecular targets; it acts through multi-component herbal synergy to modulate physiological functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoyao Heji.